Unlike previous studies, the researchers found that in their practice, no-treatment rates between elderly and nonelderly patients with biopsy-proven NMSCs were significantly different.
Survivors of childhood low-grade gliomas treated with radiotherapy have poorer neuropsychological and socioeconomic-status outcomes.
AbbVie has halted enrollment in all ongoing studies of depatuxizumab mafodotin, after an Independent Data Monitoring Committee (IDMC) recommended a phase 3 study of the treatment be stopped due to a lack of survival benefit.
Highest incidence seen for patients with non-small cell lung cancer and triple-negative breast cancer
Most patients undergoing skull base irradiation for cancer do not have detectable cognitive impairment.
The use of postoperative stereotactic radiosurgery could be a substitute for whole-brain radiotherapy, which has been linked to cognitive adverse effects.
Over 10 000 brain and CNS tumors are diagnosed in adolescent and young adults each year.
Two years post-enrollment, 43% of patients in the combination therapy group were alive.
Anthracycline-based chemotherapy was associated with worse cognitive outcomes than nonanthracycline chemo.
The adaptive trial design will allow GBM patients to benefit from precision medicine.
